A biological molecule whose presence indicates a disease or condition.A biomarker is a measurable biological molecule—such as a protein, DNA sequence, or metabolite—whose presence, absence, or altered concentration in a body fluid or tissue indicates a normal or pathological state. In medicine, biomarkers are crucial for early disease detection, prognosis, and monitoring treatment response. They also serve as biosignatures in astrobiology, where scientists search for molecular patterns that could indicate life on other planets.
The concept of biomarkers emerged in the mid-20th century with the discovery of tumor markers like alpha-fetoprotein and carcinoembryonic antigen. The term 'biomarker' gained widespread use in the 1980s, and the field expanded rapidly with the advent of genomics and proteomics.
Biomarkers are identified by comparing molecular profiles between healthy and diseased states. Techniques like mass spectrometry, immunoassays, or genomic sequencing detect and quantify specific molecules. For example, elevated levels of prostate-specific antigen (PSA) in blood can signal prostate cancer. The key is specificity: a good biomarker is uniquely associated with a condition and changes predictably with its progression.
Biomarkers are used in clinical diagnostics (e.g., troponin for heart attacks, HbA1c for diabetes), in drug development to assess efficacy and safety, and in environmental monitoring to detect exposure to pollutants. In astrobiology, they guide the search for life by identifying molecular signatures that are unlikely to form abiotically.
The 'liquid biopsy' is a revolutionary approach that detects cancer biomarkers in a simple blood sample, potentially replacing invasive tissue biopsies for monitoring tumor mutations.


















